Efficacy Study of CytoSorb Hemoperfusion Device on IL-6 Removal in ARDS/ALI Patients With Sepsis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2007
The hypothesis of this study is use of CytoSorb hemoperfusion device as an adjunctive therapy to the standard of care in treating ARDS/ALI patients in the setting of sepsis will result in improved clearance of cytokines when compared to control patients receiving only the standard of care.
Epistemonikos ID: df39d5973bf0e635a34f4bd94046aa644a59a5d4
First added on: May 04, 2024